Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Renal Insufficiency

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Renal Insufficiency in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nayak, BK1
Shanmugasundaram, K1
Friedrichs, WE1
Cavaglierii, RC1
Patel, M1
Barnes, J1
Block, K1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Renal Insufficiency

ArticleYear
HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.
    Diabetes, 2016, Volume: 65, Issue:5

    Topics: Animals; Antioxidants; Cell Line; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Extracellular M

2016